GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Value
Increase
Decrease
Funds Holding
4,279
Funds Holding Change
-74
Funds Holding Growth
-2%
Value
$885B
Holding in Top 10
524
Top 10 Change
-20
Top 10 Growth
-4%
Value Growth
-0.7%
New
175
Increased
1,927
Reduced
1,864
Closed
195
Capital Inflow
$29.6B
Capital Outflow
$32.1B
Net Capital Flow
-$2.45B
Capital Flow Change
-$11B
Calls
$9.52B
Puts
$10.3B
Net Calls
-$752M
Put/Call Ratio
1.08